Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban – an oral, direct Factor Xa inhibitor - in healthy subjects. - Mueck, W; Becka, M; Kubitza, D (Int J Clin Pharmacol Ther, 2007)
et al.